Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bioxytran Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
BIXT
Over the counter
8731
https://www.bioxytraninc.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bioxytran Inc
Bioxytran Announces Preprint of Shingles Case Study Showing Clearance Using a Topical Galectin-3 Antagonist
- Mar 6th, 2024 2:00 pm
Bioxytran’s Oral Antiviral Drug to Enter Dose Optimization Clinical Trial for COVID-19
- Feb 21st, 2024 1:00 pm
Bioxytran Gets Broad Patent Coverage on 60+ Viruses
- Oct 24th, 2023 12:45 pm
Bioxytran Interview at the Emerging Growth Conference
- Oct 4th, 2023 1:00 pm
Bioxytran Announces Broad Spectrum Antiviral Activity Highlighted in ProLectin-M
- Sep 14th, 2023 1:41 pm
Bioxytran Announces FDA Clearance of its IND Application for ProLectin-M in Clinical Trials
- Aug 24th, 2023 1:00 pm
Bioxytran Initiates a Registrational Trial of Oral ProLectin-M for Mild to Moderate COVID-19 Patients
- Aug 8th, 2023 11:00 am
Bioxytran Names Leslie Ajayi as Interim CMO and Head of the Medical Advisory Board
- Jul 31st, 2023 11:00 am
Presenting on the Emerging Growth Conference on July 12 & 13 Register Now
- Jul 11th, 2023 11:00 am
Bioxytran Peer-Reviewed Journal in “Vaccines” Contains Mechanism Capable of Targeting Future COVID-19 Mutations
- Jun 27th, 2023 11:00 am
Bioxytran Expands Institutional Investor Base with an additional $500,000 Equity Investment
- Jun 12th, 2023 1:00 pm
Presenting on the Emerging Growth Conference on May 3 Register Now
- May 2nd, 2023 11:00 am
Bioxytran Tests Acellular Oxygen Carrier BXT-25 in Pre-Clinical Trials
- Apr 19th, 2023 1:00 pm
Presenting on the Emerging Growth Conference on April 5 Register Now
- Apr 4th, 2023 11:00 am
Scroll